Indaptus Therapeutics Ownership | Who Owns Indaptus Therapeutics?


OverviewFinancialsChart

Indaptus Therapeutics Ownership Summary


Indaptus Therapeutics is owned by 5.92% institutional investors, 42.92% insiders, and 51.15% retail investors. Vanguard group is the largest institutional shareholder, holding 2.69% of INDP shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.62% of its assets in Indaptus Therapeutics shares.

INDP Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockIndaptus Therapeutics5.92%42.92%51.15%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group256.26K2.69%$215.78K
Investment house100.18K1.05%$84.36K
Geode capital management82.12K0.86%$69.15K
Strategy asset managers45.34K0.48%$38.18K
Pine valley investments ltd liability43.92K0.46%$36.99K
Renaissance27.70K0.29%$23.33K
Citadel advisors22.21K0.26%$47.09K
Vivaldi capital management lp24.00K0.25%$22.20K
Susquehanna group, llp17.83K0.19%$15.01K
Two sigma securities16.62K0.17%$14.00K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Strategy asset managers45.34K0.01%$38.18K
Investment house100.18K0.00%$84.36K
Vivaldi capital management lp24.00K0.00%$22.20K
Pine valley investments ltd liability43.92K0.00%$36.99K
Two sigma securities16.62K0.00%$14.00K
Beaird harris wealth management300.000.00%$636.00
Tower research capital llc (trc)3.51K0.00%$2.96K
Susquehanna group, llp17.83K-$15.01K
Renaissance27.70K-$23.33K
Bangor savings bank400.00-$337.00

Top Buyers

HolderShares% AssetsChange
Citadel advisors22.21K-22.21K
Susquehanna group, llp17.83K-17.83K
Two sigma securities16.62K0.00%16.62K
Geode capital management82.12K-8.99K
Ubs group2.52K-2.00K

Top Sellers

HolderShares% AssetsChange
Virtu financial---14.23K
Tower research capital llc (trc)3.51K0.00%-1.30K
Fmr---79.00
Pine valley investments ltd liability43.92K0.00%-62.00
Massmutual trust co fsb/adv---14.00

New Positions

HolderShares% AssetsChangeValue
Susquehanna group, llp17.83K-17.83K$15.01K
Two sigma securities16.62K0.00%16.62K$14.00K
Beaird harris wealth management300.000.00%300.00$636.00

Sold Out

HolderChange
Qube research-1.00
Massmutual trust co fsb/adv-14.00
Fmr-79.00
Virtu financial-14.23K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202411-35.29%563,412-6.88%511.81%4-20.00%2-50.00%
Sep 30, 202417-19.05%605,0200.85%714.02%5-44.44%433.33%
Jun 30, 20242123.53%599,9152.07%714.52%9200.00%3-40.00%
Mar 31, 202417-5.56%587,768-2.40%613.61%3-62.50%5150.00%
Dec 31, 20231812.50%602,2395.56%715.54%814.29%2-50.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv229.20K1.62%-
Fidelity Extended Market Index42.61K0.30%-271.00
Vanguard Institutional Extnd Mkt Idx Tr27.07K0.19%-
Fidelity Nasdaq Composite Index14.12K0.10%-
Fidelity Total Market Index12.95K0.09%-
Fidelity Series Total Market Index9.31K0.06%-
SSgA U.S. Extended Market Index Class I6.40K0.06%-
NT Ext Equity Mkt Idx Fd - NL6.00K0.04%-
NT Ext Equity Mkt Idx Fd - DC - NL - T24.67K0.03%-85.00
Northern Trust Extended Eq Market Idx3.59K0.03%-

Recent Insider Transactions


DateNameRoleActivityValue
Aug 14, 2023Anderson Glen R.-Buy$56.01K
Aug 10, 2023Anderson Glen R.-Buy$86.05K
Aug 11, 2023Anderson Glen R.-Buy$74.34K
Nov 22, 2022Litchev Boyan Vesselinov Chief Medical OfficerBuy$915.00
Dec 01, 2022Litchev Boyan Vesselinov Chief Medical OfficerBuy$935.45

Insider Transactions Trends


DateBuySell
2024 Q4--
2024 Q3--
2024 Q2--
2024 Q1--
2023 Q33-

INDP Ownership FAQ


Who Owns Indaptus Therapeutics?

Indaptus Therapeutics shareholders are primarily institutional investors at 5.92%, followed by 42.92% insiders and 51.16% retail investors. The average institutional ownership in Indaptus Therapeutics's industry, Biotech Stocks , is 68.48%, which Indaptus Therapeutics falls below.

Who owns the most shares of Indaptus Therapeutics?

Indaptus Therapeutics’s largest shareholders are Vanguard group (256.26K shares, 2.69%), Investment house (100.18K shares, 1.05%), and Geode capital management (82.12K shares, 0.86%). Together, they hold 4.61% of Indaptus Therapeutics’s total shares outstanding.

Does Blackrock own Indaptus Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Indaptus Therapeutics.

Who is Indaptus Therapeutics’s biggest shareholder by percentage of total assets invested?

Strategy asset managers is Indaptus Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.01% of its assets in 45.34K Indaptus Therapeutics shares, valued at 38.18K$.

Who is the top mutual fund holder of Indaptus Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Indaptus Therapeutics shares, with 1.62% of its total shares outstanding invested in 229.2K Indaptus Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools